# Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

> **NCT07447076** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Sabine Mueller, MD, PhD** · enrollment: 29 (estimated)

## Conditions studied

- Recurrent Atypical Teratoid/Rhabdoid Tumor
- Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS

## Interventions

- **PROCEDURE:** Lumber Puncture
- **PROCEDURE:** Blood Specimen Collection
- **PROCEDURE:** Magnetic resonance imaging (MRI)
- **DRUG:** Gemcitabine
- **DRUG:** Paxalisib
- **PROCEDURE:** Tumor Biopsy

## Key facts

- **NCT ID:** NCT07447076
- **Lead sponsor:** Sabine Mueller, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2035-12-31
- **Final completion:** 2036-12-31
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2026-03-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07447076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07447076, "Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07447076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
